181 results
Page 5 of 10
424B3
glhjlt6u88xarm3 caq
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
EX-10.5
ykuwg g676sdxec
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
1dfz etp5tiff2e
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.45
gkso3 ftou7
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.3
yv9hach
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.46
hnpi0 y6eyxxd
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-99.1
26xex01
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-10.2
nb50mafp
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
8-K
EX-10.1
y18q7cq5 kvqbui9
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-10.2
h2n1 uq7myinsb
1 Nov 18
Business combination disclosure
5:00pm
425
EX-10.1
z8yntukmeh8zn
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-3.1
zyp9osgje9d3 bji
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.1
3k9tyx pqr
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.2
mbuhll4i1one6b6
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
z2en8 xypk
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
8ej ndzjcp0mj5skef
9 Aug 18
Business combination disclosure
5:17pm
425
EX-3.1
yhjfgpi8
9 Aug 18
Business combination disclosure
5:17pm